{
    "name": "halobetasol topical/tazarotene",
    "comment": "Rx",
    "other_names": [
        "Duobrii"
    ],
    "classes": [
        "Antipsoriatics",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/duobrii-halobetasol-tazarotene-1000229",
    "pregnancy": {
        "common": [
            "Contraindicated in women who are pregnant",
            "Based on data from animal reproduction studies, retinoid pharmacology, and the potential for systemic absorption, fetal harm may occur when administered to a pregnant female",
            "Safety in pregnant females has not been established",
            "Consider potential risks to the fetus outweighs the potential benefit to the mother from topical lotion during pregnancy; discontinue lotion as soon as pregnancy is recognized",
            "Observational studies suggest an increased risk of low birthweight in infants with the maternal use of potent or very potent topical corticosteroids"
        ],
        "specific": [
            {
                "type": "Pregnancy testing",
                "description": [
                    "Obtain a negative result for pregnancy within 2 weeks prior to therapy, which should begin during menstruation"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Advise females of reproductive potential to use effective contraception during treatment"
                ]
            },
            {
                "type": "Tazarotene",
                "description": [
                    "Teratogenic; unknown what level of exposure is required for teratogenicity in humans",
                    "Elicits teratogenic and developmental effects associated with retinoids after topical or systemic administration in rats and rabbits"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No data available on the presence of tazarotene, halobetasol propionate, or its metabolites in human milk, effects on the breastfed infant, or effects on milk production after treatment",
            "After single topical doses of a 14C-tazarotene gel formulation to the skin of lactating rats, radioactivity was detected in rat milk",
            "Unknown whether topical corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk",
            "Advise breastfeeding women not to apply directly to nipple and areola to avoid direct infant exposure",
            "Consider developmental and health benefits of breastfeeding along with the motherâ€™s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Pregnancy"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Based on animal reproduction studies, retinoid pharmacology, and potential for systemic absorption, may cause fetal harm when administered to females of reproductive potential and is contraindicated during pregnancy (see Pregnancy)",
                "Local adverse reactions may include atrophy, striae, telangiectasias, folliculitis, and contact dermatitis; if these adverse reactions occur, discontinue treatment at least until integrity of skin is restored; do not resume treatment if allergic contact dermatitis is identified",
                "Avoid use on eczematous skin; may cause severe irritation",
                "Posterior subcapsular cataracts and glaucoma reported postmarketing with topical corticosteroid use",
                "Use appropriate antimicrobial agent if skin infection is present or develops; if favorable response does not occur promptly, discontinue until infection adequately treated"
            ],
            "specific": [
                {
                    "type": "Photosensitivity and risk for sunburn",
                    "description": [
                        "Heightens sunburn susceptibility; avoid exposure to sunlight (eg, sunlamps); if medically necessary, minimize exposure during treatment; instruct patients to use sunscreens and protective clothing",
                        "Avoid use in patients with sunburn until fully recovered; exercise caution in patients with considerable sun exposure or with inherent sensitivity to sunlight",
                        "Caution if coadministered with drugs known to be photosensitizers (eg, thiazides, tetracyclines, fluoroquinolones, phenothiazines, sulfonamides)"
                    ]
                },
                {
                    "type": "HPA axis suppression and other unwanted systemic glucocorticoid effects",
                    "description": [
                        "Halobetasol propionate has been shown to suppress of hypothalamic-pituitary-adrenal (HPA) axis",
                        "Because of the potential for systemic absorption, use of topical corticosteroids, may require evaluating patients periodically for evidence of HPA axis suppression",
                        "Consider a corticotropin stimulation test to help evaluate patients for HPA axis suppression",
                        "If HPA axis suppression is documented, attempt to gradually withdraw drug or reduce frequency of application",
                        "Systemic effects of topical corticosteroids may also include Cushing syndrome, hyperglycemia, and glucosuria"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Contact dermatitis",
            "percent": "7"
        },
        {
            "name": "Application site pain",
            "percent": "3"
        },
        {
            "name": "Folliculitis",
            "percent": "2"
        },
        {
            "name": "Skin atrophy",
            "percent": "2"
        },
        {
            "name": "Excoriation",
            "percent": "2"
        },
        {
            "name": "Rash",
            "percent": "1"
        },
        {
            "name": "Skin abrasion",
            "percent": "1"
        },
        {
            "name": "Skin exfoliation",
            "percent": "1"
        }
    ]
}